Overcoming Multidrug Resistance in Cancer: Mechanisms and Therapeutic Potential of Epigallocatechin Gallate
Life · 18.11.2026 · 16 (11) · 1952
DOI: 10.3390/life16111952 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 18.11.2026. Verfasst von Sung-Chul Lim und 3 weiteren Autor:innen. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education.
Abstract (Originalsprache)
The initial effectiveness of anticancer treatment is often undermined by tumor cell adaptation to therapeutic pressure. Epigallocatechin-3-gallate (EGCG), the principal catechin in green tea, has shown potential to restore drug sensitivity in resistant cancer cells. Previous reviews have broadly described its anticancer activities. Here, we focus on experimentally established acquired drug-resistant cancer models, distinguishing evidence for resistance reversal from general enhancement of anticancer drug activity. We also examine EGCG derivatives and nanoplatform-based delivery systems, alongside epidemiological and early clinical findings. Studies in resistant models indicate that EGCG can reduce drug efflux, inhibit pro-survival signaling, promote apoptosis, alter epigenetic regulation, and enhance drug-induced DNA damage. EGCG can also suppress epithelial–mesenchymal transition, cancer stem cell-like properties, and invasive phenotypes. Structural modification and delivery systems may improve the stability, bioavailability, tumor targeting, and therapeutic efficacy. However, evidence for reversal remains largely preclinical, and direct clinical validation in patients with treatment-resistant cancers is lacking. Further development requires formulations that achieve adequate tumor exposure and studies that establish whether the effects observed in experimental models translate into improved treatment responses in drug-resistant cancers.
Förderung
- Ministry of Education
Zitieren
APA
Lim, S., Lee, T., Choi, C. Y., & Han, S. I. (2026). Overcoming Multidrug Resistance in Cancer: Mechanisms and Therapeutic Potential of Epigallocatechin Gallate. Life, 16(11), 1952. https://doi.org/10.3390/life16111952
Vancouver
Lim S, Lee T, Choi CY, Han SI. Overcoming Multidrug Resistance in Cancer: Mechanisms and Therapeutic Potential of Epigallocatechin Gallate. Life. 2026;16(11):1952. doi:10.3390/life16111952
BibTeX
@article{Lim2026,
author = {Lim, Sung-Chul and Lee, Tae-Bum and Choi, Chul Yung and Han, Song Iy},
title = {Overcoming Multidrug Resistance in Cancer: Mechanisms and Therapeutic Potential of Epigallocatechin Gallate},
journal = {Life},
year = {2026},
volume = {16},
number = {11},
pages = {1952},
doi = {10.3390/life16111952}
}
EUVIMED